Agrios' Plant Pathology, Sixth Edition is the ultimate reference in the field. Here, Dr. Richard Oliver provides a fully updated table of contents with revised and new chapters and invited contributors from around the globe. Building on his legacy, this new edition is an essential read for students, faculty and researchers interested in plant pathology. Sections outline how to recognize, treat and prevent plant diseases and provide extensive coverage on abiotic, fungal, viral, bacterial, nematode and other plant diseases and their associated epidemiology. A large range of case studies take a deep dive into the genetics and modern management of several plant species.

This book presents a comprehensive and up to date account of the chemotherapy of parasitic diseases, both human and veterinary. The book starts with an overview of parasitic diseases. The body of the book is divided into two parts: antihelminthic drugs, and antiprotozoal drugs. Both parts start with chapters highlighting the 'biochemical targets' available for chemotherapeutic interference. Individual chapters deal with one chemical class of compounds and describe their origin, structure-activity relationship, mode of action, and methods of synthesis and their status both in clinical and veterinary practice. The book will be useful to a wide spectrum of readers: students embarking on a research career in parasitic chemotherapy, clinicians (and veterinarians) and clinical pharmacologists desiring detailed information about the drugs currently in use, and pharmaceutical technologists wanting to update their knowledge of the methods of manufacture.

This issue of Surgical Pathology Clinics, Guest Edited by Dr. Justine A. Barletta, will focus on Endocrine Pathology. Topics include, but are not limited to, Pitfalls in Thyroid Cytology, Prognostic Parameters in Differentiated Thyroid Carcinomas, Thyroid Tumors You Don't Want to Miss, Molecular Alterations in Thyroid Carcinomas, Treatment of Differentiated Thyroid Carcinomas, Treatment of Aggressive Thyroid Carcinomas, A Guide to Pheochromocytomas and Paragangliomas, A Diagnostic Approach to Adrenocortical Tumors, Treatment of Adrenocortical Carcinoma and Pheochromocytomas, Parathyroid Pathology, Neuroendocrine Tumors of the GI Tract and Pancreas, Treatment of GI Neuroendocrine Tumors, and Neuroendocrine Tumors of the Lung.

The hepatitis C virus (HCV) is a significant public health problem of international importance. HCV is capable of establishing chronic infections resulting in progressive liver damage and other problems. Current drug therapies are ineffective, highlighting the need for better antiviral drugs. Recent research in HCV genetics and molecular biology have led to significant advances in our understanding of the life cycle of this important pathogen and may ultimately lead to better antiviral strategies. The editors of this book have recruited experts from around the world to produce a timely and well-compiled review of current HCV research, with an emphasis on antiviral drug development. The chapters provide in-depth reviews of the most critical areas of research. Topics include: the HCV life cycle * HCV assays * HCV resources * HCV databases * HCV infection systems * models of hepatitis C infections * overview of the drug pipeline * clinical trial design * clinical virology and drug development * NS3 protease inhibitors * NS3-NS4A complex inhibitors * NS3 helicase inhibitors * NS4B targets and inhibitors * NS5A inhibitors * nucleoside inhibitors * NS5B polymerase inhibitors * glycoprotein-dependent entry * host cell targets and inhibitors * innate immunity for HCV antiviral therapy.

In recent years, advanced molecular techniques in diagnostic microbiology have been revolutionizing the practice of clinical microbiology in the hospital setting. Molecular diagnostic testing in general and nucleic acid-based amplification methods in particular have been heralded as diagnostic tools for the new millennium. This third edition covers not only the most recent updates and advances, but details newly invented omic techniques, such as next generation sequencing. It is divided into two distinct volumes, with Volume 1 describing the techniques, and Volume 2 addressing their applications in the field. In addition, both volumes focus more so on the clinical relevance of the test results generated by these techniques than previous editions.

This issue of Clinics in Laboratory Medicine, guest edited by Dr. Vinay Subhash Mahajan, will focus on Immunology Laboratory Testing. Topics include, but are not limited to, Analysis of proteins and immunoglobulins in the clinical immunology laboratory; Antinuclear antibody tests; Serological diagnosis of rheumatoid arthritis; ANCA; Anti-phospholipid antibodies; Diagnostic pitfalls in autoantibody testing; Analysis of the complement pathway; Flow cytometric analysis of immune cell subsets; Testing of cellular immune function in immunodeficiencies; Food allergy testing; Evaluation of the immune response in transplantation; Laboratory testing in the context of biologics and cellular therapies; Testing immune-related adverse-events in cancer immunotherapy; Molecular diagnosis of inherited immune disorders; and Future of immunology lab testing.

Alphaherpesviruses are a fascinating group of DNA viruses that include important human pathogens, such as herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus (VZV) - the causative agents of cold sores, genital ulcerous disease, and chickenpox/shingles, respectively. A key attribute of these viruses is their ability to establish lifelong latent infection in the peripheral nervous system of the host. Such persistence requires subversion of the host's immune system and intrinsic antiviral defense mechanisms. Understanding the mechanisms of the immune evasion and what triggers viral reactivation is a major challenge for today's researchers. This has prompted enormous research efforts into understanding the molecular and cellular biology of these viruses. This up-to-date and comprehensive study distills the most important research in this area, providing a timely overview of the field. Topics include: transcriptional regulation, DNA replication, translational control, virus entry and capsid assembly, the role of microRNAs in infection, and oncolytic vectors for cancer therapy. In addition, there is coverage of virus-host interactions, including apoptosis, subversion of host protein quality control and DNA damage response pathways, autophagy, establishment and reactivation from latency, interferon responses, immunity, and vaccine development. This is essential reading for everyone working with alphaherpesviruses and will be of interest to all virologists working on latent infections.

Vaccines have long been used to combat infectious diseases, however the last decade has witnessed a revolution in the approach to vaccine design and development. No longer is there a need to rely on the laborious classical methods, such as attenuation or killing the pathogen. Now, sophisticated technologies - such as genomics, proteomics, functional genomics, and synthetic chemistry - can be used for the rational identification of antigens, the synthesis of complex glycans, the generation of engineered carrier proteins, and much more. Never has research in this area been more exciting. In this book, expert international contributors critically review the current cutting-edge research in vaccine design and development. Particular emphasis is given to new approaches and technologies. The book has been divided into two parts. The first part reviews the technologies and approaches used to identify, generate, and test new vaccines. Topics include new strategies to identify protective antigens, generation of improved adjuvants, use of alternative immunization routes, improving vaccine safety, and finding and establishing the correlates of protection. The second part of the book focuses on the development of new vaccines to replace or complement currently available products or for diseases against which prophylactic strategies are missing. Examples include vaccines against nosocomial infections, streptococci, emerging viral diseases, P. aeruginosa, and bovine mastitis.

Parasiticide Discovery: In Vitro and In Vivo Tests with Relevant Parasite Rearing and Host Infection/Infestation Methods, Volume Two presents valuable screening methods that have led to the discovery of the majority of parasiticides commercialized in the animal health industry. As much of the knowledge of parasiticide discovery methods is being lost in the animal health industry as seasoned parasitologists retire, this book serves to preserve valuable methods that have led to the discovery of the majority of parasiticides commercialized in animal health, also giving insights into the in vitro and in vivo methods used to identify the parasiticide activity of compounds.

Parasiticide Discovery: In Vitro and In Vivo Tests with Relevant Parasite Rearing and Host Infection/Infestation Methods, Volume One presents valuable screening methods that have led to the discovery of the majority of parasiticides commercialized in the animal health industry. As much of the knowledge of parasiticide discovery methods is being lost in the animal health industry as seasoned parasitologists retire, this book serves to preserve valuable methods that have led to the discovery of the majority of parasiticides commercialized in animal health, also giving insights into the in vitro and in vivo methods used to identify the parasiticide activity of compounds.

This issue of Surgical Pathology Clinics, Guest Edited by Dr. Brooke Howitt, will focus on practical issues and updates around Gynecologic Pathology. This issue is one of four selected each year by the series Consulting Editor, Jason L. Hornick. Topics include, but are not limited to, Non-HPV associated squamous neoplasia of the vulva and vagina; HPV-associated squamous neoplasia of the lower female genital tract; Cervical glandular neoplasia: classification and staging; Preinvasive lesions of the endometrium; Endometrial carcinoma: Grossing, frozen section evaluation, staging, and senitnel lymph node evaluation; High grade endometrial carcinomas: Classification with molecular insights; Uterine mesenchymal tumors: Classification, staging, and updates in molecular testing; Smooth muscle neoplasia of the female genital tract; Germ cell tumors of the female genital tract; Fallopian tube neoplasia and mimics; Low grade serous neoplasia of the female genital tract; Ovarian high grade serous carcinoma: Staging, assessing site of origin and the post-neoadjuvant chemotherapy setting; Ovarian mucinous tumors; Endometrioid and clear cell tumors of the ovary; and Ovarian sex cord stromal tumors.

This book offers the first comprehensive review of parasitic Crustacea, which are among the most successful and diverse parasites. Starting with an introductory chapter, followed by an historic overview and topic-specific chapters, each presenting a different aspect of parasitic crustacean biology, it enables readers to gain a better understanding of how these parasites function and allows direct comparisons between the different parasitic crustacean groups. The authors also discuss, in depth, the adaptations and interactions that have made parasitic Crustacea as successful as they are today, covering topics ranging from the history of their discovery, their biodiversity, phylogeny, evolution and life strategies to their role as vectors, or hosts of other organisms, and their significance in ecological processes. Consisting of ten chapters from leading international experts in the field, this volume offers a one-stop resource for all researchers, lecturers, students and practitioners.

A valuable, new source, Molecular Medical Parasitology is the only text of its kind -- one that applies broad concepts and current scientific advances from both molecular biology and biochemistry to the study of parasitic organisms. An internationally renowned team of scientists and physicians places parasites in their broad biological contexts while still emphasizing the specifics that differentiate these organisms. Not only will researchers and faculty in parasitology find this an indispensable guide, physicians will benefit from the thorough coverage molecular biology and biochemistry's current influences on treatment and management of parasitic diseases.
Key Features
* Features the most up-to-date scientific methods behind the medical management of parasitic diseases
* Applies the most current synthesis of molecular biology and biochemistry to parasitic organisms
* Contains many informative figures and clear illustrations

Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action is exerted in target tissues via binding the androgen receptor (AR), a nuclear receptor transcription factor.

Historically, the gene expression program mediated by the AR has been poorly understood. However, recent gene expression profiling and more traditional single-gene characterization studies have revealed many androgen-regulated genes that are important mediators of androgen action in both normal and malignant prostate tissue. This book will focus on the androgen-regulated gene expression program, and examine how recently identified androgen-regulated genes are likely to contribute to the development and progression of prostate cancer. Recent studies that have attempted to unravel how these genes are deregulated in androgen depletion independent prostate cancer will be included

The book starts with a general introduction into the relevance of systems biology for understanding tuberculosis. This will be followed by several chapters which describe the application of systems biology to various aspects of the study of the pathogen, Mycobacterium tuberculosis, and its interaction with the host. The book provides the reader with an account of how the new science of systems biology is providing novel insights into the ancient scourge of tuberculosis. It will also describe how systems biology can be applied to the control of tuberculosis, including the development of new treatments, vaccines and diagnostics.

Viruses are the agent responsible for perhaps up to one million cases of cancer worldwide each year. Significantly, the study of viruses has also provided important clues to the causes and development of the most common human cancers. This volume presents an account of those viruses which have been directly associated with common human malignancies such as human papillomavirus (HPV), cervical carcinoma, Epstein-Barr virus (EBV) and Burkitt's lymphoma. In addition, the biology and biochemistry of those viruses which have been shown to be capable of transforming cells in culture are described in detail. Thus adenovirus are discussed, as are the other small DNA tumour viruses - Simian virus 40 (SV40) and polyoma virus. Consideration has also been given to human T-cell leukaemia virus (HTLV), hepatitis B virus (HBV) and human herpes virus 8 (HHV8), amongst others. General themes such as the host's immune response to viral infection, virally-induced apoptosis and the use of viruses as a delivery system in gene therapy have been discussed.
Individual chapters have been written by an international group of experts in their own field of research.

This text was developed with the practicing physician in mind, however, it will be of considerable interest to the virologist, pharmacologist, chemist and all scientists interested in antiviral agents.

Progress in the field of antiviral development is now moving rapidly and there is hope that one day there will be successful treatment modalities for most viral diseases. This work contains contributions from experts around the world, capturing worldwide practices.

An online version providing the current status of antiviral research is planned for the near future.